The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Uromedica sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Uromedica Inc (Uromedica) is a medical device company that develops, manufactures, markets and sells equipment for the urological market. It develops minimally invasive medical products such as urological implants using its patented adjustable balloon technology. Uromedica’s Adjustable Continence Therapy is designed to treat female patients who have stress urinary incontinence arising from intrinsic sphincter deficiency. The company offers ProACT, which is designed to treat male patients who have intrinsic sphincter deficiency. It has distribution network across the US and Australia. Uromedica is headquartered in Plymouth, Minnesota, the US.
The key metrics of Uromedica related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Uromedica is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Uromedica.
For a detailed understanding of the performance of Uromedica, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
